Forecast

Buy	0
Hold	0
Sell	1

News Go to news feed

Spire Healthcare accepts takeover offer worth £1.03 billion

Spire Healthcare agreed to a takeover offer from a consortium that includes funds managed by Toscafund, Three Hills and Ares. Shareholders will receive 250 pence per share in cash, valuing the equity at around £1.03 billion. The stock then rose by more than 3% to 245.5 pence, reaching a one-year high. » More on de.investing.com
Takeover deadline for Spire Healthcare by Toscafund extended by one day

Toscafund has extended the deadline to submit a binding offer for Spire Healthcare to Friday at 17:00 London time in order to finalise financing documents. The potential cash offer amounts to 250 pence per share; due diligence is complete and the transaction documentation is nearly final. Toscafund may reduce the offer under certain conditions, and there is no certainty that a binding offer will actually be made. » More on de.investing.com
Spire Healthcare: takeover deadline for Toscafund extended by one day to 4 September

The board of Spire Healthcare said the deadline for a binding takeover offer from Toscafund Asset Management has been extended by one day to 4 September 2026. Toscafund announced a cash offer of 250 pence per share in May and confirmed that due diligence is complete, but still requires financing documentation and the final transaction documents. The offer remains subject to customary conditions, Toscafund reserves the right in certain circumstances to reduce the offer, and there is no certainty that a binding offer will actually be made. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Spire Healthcare Group has already paid €0.0173 in dividends. The last payout was in June.

Financials

In the last quarter, Spire Healthcare Group had revenue of €897.56m and net profit of €11.35m

(EUR)	December 2025	YoY
Revenue	897.56m	-
Gross profit	338.35m	-
Net profit	11.35m	-
EBITDA	147.4m	-

Fundamentals

Metric	Value
Market capitalization	€1.15bn
Number of shares	400.6m
52-week high/low	€2.99 - €1.64
Dividend yield	0.60%
Dividends TTM	€0.0173
Beta	0.93
P/E ratio	60.44
PEG ratio	-1.71
P/B ratio	1.33
P/S ratio	0.62

Company profile

Die Spire Healthcare Group plc besitzt und betreibt zusammen mit ihren Tochtergesellschaften private Krankenhäuser und Kliniken. Sie bietet verschiedene Behandlungen in den Bereichen Allergie und Infektionskrankheiten, Bluttests, Knochen und Gelenke, Darmbehandlungen, Brustuntersuchungen, Krebsuntersuchungen und -behandlungen, kosmetische Chirurgie, Zystenentfernung und Zahnchirurgie sowie Hals-Nasen-Ohren-Behandlungen an. Das Unternehmen bietet auch Augenoperationen und -behandlungen, Familienplanung, Gastroenterologie, Allgemeinmedizin, Allgemeinchirurgie, Hämatologie, Handchirurgie, Hüft- und Kniebehandlungen sowie Herz- und Nierenbehandlungen an. Darüber hinaus bietet es Behandlungen in den Bereichen Männergesundheit, Neurochirurgie und Neurologie, Pädiatrie, Schmerztherapie, Rehabilitation, Sport, Physiotherapie, Podologie, Atemwegserkrankungen und Rheumatologie sowie Scans und Untersuchungen, Hautbehandlungen, Wirbelsäulenbehandlungen, Sportwissenschaften, urologische Behandlungen, Gefäßchirurgie, Gewichtsabnahme und Frauengesundheit. Darüber hinaus bietet das Unternehmen verschiedene Tests und Untersuchungen an, darunter Herz-CT, CT, MRT, Ultraschall und Röntgenuntersuchungen. Das Unternehmen bietet in 40 Krankenhäusern und acht Kliniken in England, Wales und Schottland Diagnostik, stationäre, teilstationäre und ambulante Pflegeleistungen an. Die Spire Healthcare Group plc wurde 2007 gegründet und hat ihren Hauptsitz in London, Vereinigtes Königreich.